Cargando…
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
BACKGROUND: Guidelines for anal cancer recommend assessment of response at 6–12 weeks after starting treatment. Using data from the ACT II trial, we determined the optimum timepoint to assess clinical tumour response after chemoradiotherapy. METHODS: The previously reported ACT II trial was a phase...
Autores principales: | Glynne-Jones, Robert, Sebag-Montefiore, David, Meadows, Helen M, Cunningham, David, Begum, Rubina, Adab, Fawzi, Benstead, Kim, Harte, Robert J, Stewart, Jill, Beare, Sandy, Hackshaw, Allan, Kadalayil, Latha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337624/ https://www.ncbi.nlm.nih.gov/pubmed/28209296 http://dx.doi.org/10.1016/S1470-2045(17)30071-2 |
Ejemplares similares
-
Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost
por: Melcher, A A, et al.
Publicado: (2003) -
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study
por: Glynne-Jones, R, et al.
Publicado: (2007) -
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study
por: Sebag-Montefiore, D, et al.
Publicado: (2005) -
Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
por: Tobias, Jeffrey S, et al.
Publicado: (2009) -
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
por: Northover, J, et al.
Publicado: (2010)